Literature DB >> 27156076

Psoriatic arthritis and psoriasis: differential diagnosis.

Maddalena Napolitano1, Francesco Caso2, Raffaele Scarpa2, Matteo Megna1, Angela Patrì1, Nicola Balato1, Luisa Costa3.   

Abstract

Psoriasis frequency ranges from 1 to 3 % in white population, and arthritis occurs in 10-40 % of psoriasis patients, representing a relevant health issue. Psoriatic arthritis (PsA) is an inflammatory arthropathy, associated with psoriasis, in which ocular-, intestinal-, metabolic-, and cardiovascular-related manifestations can variably coexist. In order to favor early PsA and psoriasis diagnosis, it is crucial to rule out other conditions that can resemble the disease and delay appropriate therapeutic approach. Therefore, the aim of this review is to focus on PsA and psoriasis differential diagnosis.

Entities:  

Keywords:  Differential diagnosis; Psoriasis; Psoriatic arthritis

Mesh：

Year:  2016        PMID： 27156076     DOI： 10.1007/s10067-016-3295-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  104 in total

Review 1.  Interleukin-17 and innate immunity in infections and chronic inflammation.

Authors:  Natasa Isailovic; Kenji Daigo; Alberto Mantovani; Carlo Selmi
Journal:  J Autoimmun       Date:  2015-05-18       Impact factor: 7.094

2.  Erosive osteoarthritis and the main en lorgnette deformity (opera glass hand).

Authors:  Robert L Swezey; Stanley J Alexander
Journal:  Arch Intern Med       Date:  1971-08

Review 3.  Psoriatic Arthritis Mutilans: Clinical and Radiographic Criteria. A Systematic Review.

Authors:  Amir Haddad; Sindhu R Johnson; Mansour Somaily; Rouhi Fazelzad; Amie T Kron; Cathy Chau; Vinod Chandran
Journal:  J Rheumatol       Date:  2015-06-15       Impact factor: 4.666

4.  Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model.

Authors:  P S Helliwell; J Hetthen; K Sokoll; M Green; A Marchesoni; E Lubrano; D Veale; P Emery
Journal:  Arthritis Rheum       Date:  2000-04

5.  Histopathological findings are associated with the clinical types of psoriasis but not with the corresponding lesional psoriasis severity index.

Authors:  Byung Yoon Kim; Jae Woo Choi; Bo Ri Kim; Sang Woong Youn
Journal:  Ann Dermatol       Date:  2015-02-03       Impact factor: 1.444

Review 6.  Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.

Authors:  Francesco Caso; Luca Cantarini; Filomena Morisco; Antonio Del Puente; Roberta Ramonda; Ugo Fiocco; Ennio Lubrano; Rosario Peluso; Paolo Caso; Mauro Galeazzi; Leonardo Punzi; Raffaele Scarpa; Luisa Costa
Journal:  Expert Opin Biol Ther       Date:  2015-02-04       Impact factor: 4.388

7.  Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

Authors:  S M Jones; J B Armas; M G Cohen; C R Lovell; G Evison; N J McHugh
Journal:  Br J Rheumatol       Date:  1994-09

8.  [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases].

Authors:  A M Chamot; C L Benhamou; M F Kahn; L Beraneck; G Kaplan; A Prost
Journal:  Rev Rhum Mal Osteoartic       Date:  1987-03

9.  Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.

Authors:  Fiona E McCann; Andrew C Palfreeman; Melanie Andrews; Dany P Perocheau; Julia J Inglis; Peter Schafer; Marc Feldmann; Richard O Williams; Fionula M Brennan
Journal:  Arthritis Res Ther       Date:  2010-06-02       Impact factor: 5.156

10.  The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection.

Authors:  Mariangela Atteno; Luisa Costa; Alessandro Matarese; Francesco Caso; Antonio Del Puente; Luca Cantarini; Maria Luisa Bocchino; Alessandro Sanduzzi; Raffaele Scarpa
Journal:  Clin Rheumatol       Date:  2014-02-21       Impact factor: 2.980
View more
  15 in total

Review 1.  Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study.

Authors:  Francesco Caso; Antonio Del Puente; Francesca Oliviero; Rosario Peluso; Nicolò Girolimetto; Paolo Bottiglieri; Francesca Foglia; Carolina Benigno; Marco Tasso; Leonardo Punzi; Raffaele Scarpa; Luisa Costa
Journal:  Clin Rheumatol       Date:  2018-01-08       Impact factor: 2.980

2.  Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules".

Authors:  Matteo Megna; Anna Balato; Maddalena Napolitano; Lucia Gallo; Francesco Caso; Luisa Costa; Nicola Balato; Raffaele Scarpa
Journal:  Clin Rheumatol       Date:  2018-04-11       Impact factor: 2.980

3.  Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.

Authors:  Maddalena Napolitano; Luisa Costa; Francesco Caso; Matteo Megna; Raffaele Scarpa; Nicola Balato; Fabio Ayala; Anna Balato
Journal:  Clin Rheumatol       Date:  2017-05-31       Impact factor: 2.980

4.  Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting.

Authors:  Luca Navarini; Luisa Costa; Marco Tasso; Maria Sole Chimenti; Damiano Currado; Giulia Lavinia Fonti; Massimo Ciccozzi; Domenico Paolo Emanuele Margiotta; Carolina Benigno; Erica De Martino; Roberto Perricone; Antonella Afeltra; Raffaele Scarpa; Francesco Caso
Journal:  Clin Rheumatol       Date:  2020-03-18       Impact factor: 2.980

Review 5.  Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management.

Authors:  Francesco Caso; Marco Tasso; Maria Sole Chimenti; Luca Navarini; Carlo Perricone; Nicolò Girolimetto; Rosario Peluso; Antonio Del Puente; Antonella Afeltra; Roberto Perricone; Leonardo Punzi; Raffaele Scarpa; Luisa Costa
Journal:  Drugs Aging       Date:  2019-10       Impact factor: 3.923

Review 6.  Psoriasis and Gut Microbiome-Current State of Art.

Authors:  Karina Polak; Beata Bergler-Czop; Michał Szczepanek; Kamila Wojciechowska; Aleksandra Frątczak; Norbert Kiss
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

Review 7.  Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist.

Authors:  Luigi Barrea; Maria Cristina Savanelli; Carolina Di Somma; Maddalena Napolitano; Matteo Megna; Annamaria Colao; Silvia Savastano
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

8.  Effects of Dietary Protein Intake on Cutaneous and Systemic Inflammation in Mice with Acute Experimental Psoriasis.

Authors:  Tanja Knopp; Tabea Bieler; Rebecca Jung; Julia Ringen; Michael Molitor; Annika Jurda; Thomas Münzel; Ari Waisman; Philip Wenzel; Susanne Helena Karbach; Johannes Wild
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

9.  Is there any link between tumor-induced osteomalacia and psoriasis? A case report.

Authors:  Mojtaba Akbari; Bagher Larijani; Sasan Sharghi; Ali Jalili; Sayed Mahmoud Sajjadi-Jazi
Journal:  J Diabetes Metab Disord       Date:  2017-08-23

10.  A Multimodal Eye Assessment in Psoriatic Arthritis Patients sine-Psoriasis: Evidence for a Potential Association with Systemic Inflammation.

Authors:  Maria Sole Chimenti; Paola Triggianese; Giorgia Salandri; Paola Conigliaro; Claudia Canofari; Francesco Caso; Luisa Costa; Carlo Nucci; Francesco Aiello; Massimo Cesareo; Roberto Perricone
Journal:  J Clin Med       Date:  2020-03-06       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.